The Slovak Medicines Agency announced that the Russian manufacturer of the covid-19 Sputnik V vaccine did not provide the required vaccine shipment data to Slovakia, which claimed to be different from the data analyzed by the European Medicines Agency and the medical journal The Lancet.
The SUKL Drug Administration also reiterated that it cannot determine the benefits and risks of the vaccine. Slovakia imported 200,000 doses of Sputnik V last month, but it has not yet started to use them.
SUKL stated that it has not succeeded in requesting additional data on preclinical trials, production and clinical trials of Russian vaccines.
The agency pointed out: “Even if the request is repeated, it will not provide a large part of the data (nearly 80%).”
SUKL pointed out that the vaccine formulation is different from the product EMA is considering.
The goods sent to Slovakia also have different characteristics from the goods used in the study published in the magazine “The Lancet”. Slovak experts support the claim that the vaccine should be purchased.
The Russian Direct Investment Fund (RDIF), which sells Sputnik V abroad, announced on Thursday that Slovakia should refund the controversial dose. RDIF announced on its official Twitter account that it has sent a letter requesting the return of these doses and requesting that it be sent to an accredited laboratory for further inspection.
The Russian Ministry of Health at the Gamaley Institute, which is responsible for developing the vaccine, has not yet commented on this.
The official Twitter profile of Sputnik V announced on Wednesday that there were reports that the vaccines sent to Slovakia and the vaccines used in clinical trials were “falsified.”
Igor Matovic, the Minister of Finance of Slovakia, agreed to buy the post of Prime Minister of Sputnik V. He plans to meet with RDIF Director Kirill Dmitrieje in Moscow on Thursday. (Kirill Dmitriev) met to resolve the vaccine dispute.
Matovic had to resign to buy Russian vaccines.
The Ministry of Health of Slovakia stated that further measures regarding the use of Sputnik V will be announced next week.